CAPTIV8 Share vs Ankyras
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
CAPTIV8 Share
Easily share medical animations with patients via SMS or email. This app also enables secure telemedicine consultations and posting animations to social media. It requires a paid subscription for use by eye care professionals.
- Share patient animations via SMS/email
- Secure telemedicine consultations
- Post animations to social media
- Patient education tool
- HIPAA compliant
Read full descriptionHide full description
CAPTIV8 Share allows you to easily send patients CAPTIV8 animations to via SMS or email. CAPTIV8 Share requires a paid subscription, it is for Ophthalmologists and Optometrists as part of their consultation and patient education. CAPTIV8 Share will also enable clinicians to perform fully compliant and secure Telemedicine consultations. Finally, as part of this new release, clinicians can also post animations to their social media channels.
Ankyras
Read full descriptionHide full description
Ankyras makes the intracranial aneurysm treatment planning easier, accessible and more interactive. Intended use: Ankyras is a medical software intended to assist healthcare professionals in the selection of a proper braided stent device for the treatment of intracranial aneurysms. • Login for full access: Registered users can log in to access their case list and saved simulations. (Note: Medical images cannot be viewed on the mobile app.) • Access without login: Unregistered users can still open shared simulations without logging in. Shared cases can be accessed directly via a “View Case” email link. • Open shared simulations – You will receive an email when another user share a simulation with you. In the mail, click View case: Ankyras app will directly open the case. • Vessel morphology – Explore and quantify the vessel morphology to assess the fit of the desired braided device in the patients’ anatomy. • See, move and change FD devices – easily simulate the different devices and adjust their position if needed along the vessel. • Share simulations – Click the left corner menu button and share the simulation with others to facilitate case discussion. Ankyras includes both a free-registration version and a user-registration version with complete case processing features. You can get registered in www.ankyrasonline.com from a laptop or PC to get access to all simulation processing functionalities. The Ankyras support team will be in contact with you and facilitate the indications and instructions to start preparing your own simulations. Ankyras is a Medical Device manufactured by Mentice Spain S.L. and distributed by Mentice subsidiaries and partners in approved markets. Mentice Spain S.L. (SRN: ES-MF-000036826) is ISO 13485 certified with number MD 784027. Ankyras is CE marked under MDR (MDR 784032) and holds UKCA certification (UKCA 784033). It is 510(k) cleared by the FDA (K230006) and notified to ANVISA (registration number 81118630030). Ankyras v6.0-CE UDI-DI: 8437025622023. NB 2797 All operators must read the complete Instructions for Use before operating the ANKYRAS. The product should be used only by qualified and trained personnel. ANKYRAS is intended for exclusive use by professional users. The software is intended to assist healthcare professionals in the planning of endovascular treatment with flow diverters and cannot fully substitute their clinical judgement. The software should only be used in combination with equipment with the minimum system requirements listed. If the minimum system requirements are not met the system may not work as expected. For more information, please refer to the eIFU, available here: https://www.mentice.com/ankyras/ifu
Screenshots
Verdict
The clearest difference is iOS requirement: Ankyras at 12.0 against CAPTIV8 Share's 18.6. On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
CAPTIV8 Share ships an update monthly, Ankyras every 2 months. The most recent releases landed on October 8, 2026 and October 21, 2026 respectively.
| Parameter | CAPTIV8 Share | Ankyras |
|---|---|---|
| Price | Free | Free |
| Rating | 1.0 (1 ratings) — better | — |
| Number of ratings | 1 — better | — |
| Update frequency | Monthly — better | Every 2 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Subscription | — |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 18.6 | 12.0 — better |
| Further details — not scored | ||
| Size | 35 MB | 76 MB |
| Age rating | 12+ | 4+ |
| Developer | Optimed Limited | Galgo Medical S.L. |
In-app purchases
CAPTIV8 Share
No in-app purchases
Ankyras
No in-app purchases
Questions
Is CAPTIV8 Share free?
Is Ankyras free?
Do CAPTIV8 Share or Ankyras have ads?
Which is updated more often, CAPTIV8 Share or Ankyras?
Other comparisons















